Quotes 5-day view Delayed Nyse
01/11/2021
01/12/2021
01/13/2021
01/14/2021
01/15/2021
Date
37.77(c)
37.18(c)
36.86(c)
36.75(c)
36.7(c)
Last
47 326 586
47 831 077
31 027 868
30 271 992
33 803 493
Volume
+1.72% -1.56% -0.86% -0.30% -0.14% Change
Sales 2020
48 571 M - -
Net income 2020
17 066 M - -
Net Debt 2020
43 571 M - -
P/E ratio 2020
13,3x
Yield 2020
3,92%
Sales 2021
53 585 M - -
Net income 2021
14 926 M - -
Net Debt 2021
33 760 M - -
P/E ratio 2021
15,3x
Yield 2021
4,22%
Capitalization
204 B 204 B -
EV / Sales 2020
5,10x
EV / Sales 2021
4,44x
Nbr of Employees
88 300
Free-Float
59,1%
Pfizer Inc. (Pfizer) is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development and manufacture of healthcare products. Its global portfolio includes medicines and vaccines. The Company manages its commercial operations through two business segments: Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). IH focuses on developing and commercializing medicines...
Notations Surperformance© of Pfizer Inc.
Trading Rating : Investor Rating :
All news about PFIZER INC.
News in other languages on PFIZER INC.
Analyst Recommendations on PFIZER INC.
PFIZER INC. - 2020
Close to new upside potential
BUY
REFILE-Pfizer forecasts 2021 earnings of $3 to $3.10 per share
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends PFIZER INC.
Short Term Mid-Term Long Term Trends Bearish Neutral Bullish
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
22
Average target price
41,94 $
Last Close Price
36,70 $
Spread / Highest target
44,4%
Spread / Average Target
14,3%
Spread / Lowest Target
-1,91%
Please enable JavaScript in your browser's settings to use dynamic charts.
Canada
Deutschland
España
France
Italia
Schweiz (DE)
United Kingdom
Report
